MAPT and diabetes mellitus: Simultaneously, some scholars have suggested that under diabetes-induced metabolic stress, abnormal GSK-3β activation drives p-tau and downregulation of β-catenin, resulting in synaptic neurodegeneration preceding mitochondrial impairment and apoptosis of RGCs [134].